ProShare Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $391K | Sell |
|
|||||
|
2025
Q1 | $425K | Sell |
|
|||||
|
2024
Q4 | $393K | Sell |
|
|||||
|
2024
Q3 | $511K | Sell |
|
|||||
|
2024
Q2 | $488K | Sell |
|
|||||
|
2024
Q1 | $608K | Buy |
|
|||||
|
2023
Q4 | $461K | Sell |
|
|||||
|
2023
Q3 | $349K | Buy |
|
|||||
|
2023
Q2 | $330K | Sell |
|
|||||
|
2023
Q1 | $423K | Sell |
|
|||||
|
2022
Q4 | $564K | Sell |
|
|||||
|
2022
Q3 | $482K | Buy |
|
|||||
|
2022
Q2 | $402K | Sell |
|
|||||
|
2022
Q1 | $673K | Sell |
|
|||||
|
2021
Q4 | $1.05M | Sell |
|
|||||
|
2021
Q3 | $1.78M | Buy |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $930K | Sell |
|
|||||
|
2020
Q4 | $1.33M | Buy |
|
|||||
|
2020
Q3 | $1.16M | Buy |
|
|||||
|
2020
Q2 | $1.09M | Buy |
|
|||||
|
2020
Q1 | $711K | Sell |
|
|||||
|
2019
Q4 | $1.38M | Sell |
|
|||||
|
2019
Q3 | $1.19M | Sell |
|
|||||
|
2019
Q2 | $1.51M | Sell |
|
|||||
|
2019
Q1 | $1.61M | Buy |
|
|||||
|
2018
Q4 | $843K | Sell |
|
|||||
|
2018
Q3 | $1.14M | Buy |
|
|||||
|
2018
Q2 | $1.05M | Buy |
|
|||||
|
2018
Q1 | $987K | Sell |
|
|||||
|
2017
Q4 | $691K | Buy |
|